197 related articles for article (PubMed ID: 38814397)
1. Electroporation of mRNA as a Universal Technology Platform to Transfect a Variety of Primary Cells with Antigens and Functional Proteins.
Sauerer T; Albrecht L; Sievers NM; Gerer KF; Hoyer S; Dörrie J; Schaft N
Methods Mol Biol; 2024; 2786():219-235. PubMed ID: 38814397
[TBL] [Abstract][Full Text] [Related]
2. Electroporation of mRNA as Universal Technology Platform to Transfect a Variety of Primary Cells with Antigens and Functional Proteins.
Gerer KF; Hoyer S; Dörrie J; Schaft N
Methods Mol Biol; 2017; 1499():165-178. PubMed ID: 27987149
[TBL] [Abstract][Full Text] [Related]
3. Highly efficient gene delivery by mRNA electroporation in human hematopoietic cells: superiority to lipofection and passive pulsing of mRNA and to electroporation of plasmid cDNA for tumor antigen loading of dendritic cells.
Van Tendeloo VF; Ponsaerts P; Lardon F; Nijs G; Lenjou M; Van Broeckhoven C; Van Bockstaele DR; Berneman ZN
Blood; 2001 Jul; 98(1):49-56. PubMed ID: 11418462
[TBL] [Abstract][Full Text] [Related]
4. RNA-transfection of γ/δ T cells with a chimeric antigen receptor or an α/β T-cell receptor: a safer alternative to genetically engineered α/β T cells for the immunotherapy of melanoma.
Harrer DC; Simon B; Fujii SI; Shimizu K; Uslu U; Schuler G; Gerer KF; Hoyer S; Dörrie J; Schaft N
BMC Cancer; 2017 Aug; 17(1):551. PubMed ID: 28818060
[TBL] [Abstract][Full Text] [Related]
5. Langerhans-type and monocyte-derived human dendritic cells have different susceptibilities to mRNA electroporation with distinct effects on maturation and activation: implications for immunogenicity in dendritic cell-based immunotherapy.
Chung DJ; Romano E; Pronschinske KB; Shyer JA; Mennecozzi M; St Angelo ET; Young JW
J Transl Med; 2013 Jul; 11():166. PubMed ID: 23837662
[TBL] [Abstract][Full Text] [Related]
6. Efficient genetic modification of murine dendritic cells by electroporation with mRNA.
Van Meirvenne S; Straetman L; Heirman C; Dullaers M; De Greef C; Van Tendeloo V; Thielemans K
Cancer Gene Ther; 2002 Sep; 9(9):787-97. PubMed ID: 12189529
[TBL] [Abstract][Full Text] [Related]
7. In vivo depletion of CD4+CD25+ regulatory T cells enhances the antigen-specific primary and memory CTL response elicited by mature mRNA-electroporated dendritic cells.
Van Meirvenne S; Dullaers M; Heirman C; Straetman L; Michiels A; Thielemans K
Mol Ther; 2005 Nov; 12(5):922-32. PubMed ID: 16257383
[TBL] [Abstract][Full Text] [Related]
8. Studies on mRNA electroporation of immature and mature dendritic cells: effects on their immunogenic potential.
Met O; Eriksen J; Svane IM
Mol Biotechnol; 2008 Oct; 40(2):151-60. PubMed ID: 18543130
[TBL] [Abstract][Full Text] [Related]
9. An improved protocol for generation of immuno-potent dendritic cells through direct electroporation of CD14+ monocytes.
Milano F; van Baal JW; Rygiel AM; Bergman JJ; Van Deventer SJ; Kapsenberg ML; Peppelenbosch MP; Krishnadath KK
J Immunol Methods; 2007 Apr; 321(1-2):94-106. PubMed ID: 17336322
[TBL] [Abstract][Full Text] [Related]
10. An accelerated, clinical-grade protocol to generate high yields of type 1-polarizing messenger RNA-loaded dendritic cells for cancer vaccination.
Brabants E; Heyns K; De Smet S; Devreker P; Ingels J; De Cabooter N; Debacker V; Dullaers M; VAN Meerbeeck JP; Vandekerckhove B; Vermaelen KY
Cytotherapy; 2018 Sep; 20(9):1164-1181. PubMed ID: 30122654
[TBL] [Abstract][Full Text] [Related]
11. Enhanced dendritic cell antigen presentation in RNA-based immunotherapy.
Kalady MF; Onaitis MW; Padilla KM; Emani S; Tyler DS; Pruitt SK
J Surg Res; 2002 Jun; 105(1):17-24. PubMed ID: 12069496
[TBL] [Abstract][Full Text] [Related]
12. High-efficiency transfection of primary human and mouse T lymphocytes using RNA electroporation.
Zhao Y; Zheng Z; Cohen CJ; Gattinoni L; Palmer DC; Restifo NP; Rosenberg SA; Morgan RA
Mol Ther; 2006 Jan; 13(1):151-9. PubMed ID: 16140584
[TBL] [Abstract][Full Text] [Related]
13. Increased cytotoxic capacity of tumor antigen specific human T cells after in vitro stimulation with IL21 producing dendritic cells.
Turksma AW; Bontkes HJ; Ruizendaal JJ; van den Heuvel H; Scholten KB; Santegoets SJ; de Gruijl TD; Meijer CJ; Hooijberg E
Hum Immunol; 2013 May; 74(5):506-13. PubMed ID: 23376456
[TBL] [Abstract][Full Text] [Related]
14. Single-step antigen loading and activation of dendritic cells by mRNA electroporation for the purpose of therapeutic vaccination in melanoma patients.
Bonehill A; Van Nuffel AM; Corthals J; Tuyaerts S; Heirman C; François V; Colau D; van der Bruggen P; Neyns B; Thielemans K
Clin Cancer Res; 2009 May; 15(10):3366-75. PubMed ID: 19417017
[TBL] [Abstract][Full Text] [Related]
15. Lumenal part of the DC-LAMP protein is not required for induction of antigen-specific T cell responses by means of antigen-DC-LAMP messenger RNA-electroporated dendritic cells.
De Keersmaecker B; Heirman C; Allard S; Bonehill A; Corthals J; Thielemans K; Aerts JL
Hum Gene Ther; 2010 Apr; 21(4):479-85. PubMed ID: 19903083
[TBL] [Abstract][Full Text] [Related]
16. Induction of Influenza Matrix Protein 1 and MelanA-specific T lymphocytes in vitro using mRNA-electroporated dendritic cells.
Tuyaerts S; Michiels A; Corthals J; Bonehill A; Heirman C; de Greef C; Noppe SM; Thielemans K
Cancer Gene Ther; 2003 Sep; 10(9):696-706. PubMed ID: 12944989
[TBL] [Abstract][Full Text] [Related]
17. Ex vivo induction of viral antigen-specific CD8 T cell responses using mRNA-electroporated CD40-activated B cells.
Van den Bosch GA; Ponsaerts P; Nijs G; Lenjou M; Vanham G; Van Bockstaele DR; Berneman ZN; Van Tendeloo VF
Clin Exp Immunol; 2005 Mar; 139(3):458-67. PubMed ID: 15730391
[TBL] [Abstract][Full Text] [Related]
18. Side-by-side comparison of lentivirally transduced and mRNA-electroporated dendritic cells: implications for cancer immunotherapy protocols.
Dullaers M; Breckpot K; Van Meirvenne S; Bonehill A; Tuyaerts S; Michiels A; Straetman L; Heirman C; De Greef C; Van Der Bruggen P; Thielemans K
Mol Ther; 2004 Oct; 10(4):768-79. PubMed ID: 15451461
[TBL] [Abstract][Full Text] [Related]
19. Selective modification of antigen-specific T cells by RNA electroporation.
Mitchell DA; Karikari I; Cui X; Xie W; Schmittling R; Sampson JH
Hum Gene Ther; 2008 May; 19(5):511-21. PubMed ID: 18471037
[TBL] [Abstract][Full Text] [Related]
20. A GMP-compliant protocol to expand and transfect cancer patient T cells with mRNA encoding a tumor-specific chimeric antigen receptor.
Krug C; Wiesinger M; Abken H; Schuler-Thurner B; Schuler G; Dörrie J; Schaft N
Cancer Immunol Immunother; 2014 Oct; 63(10):999-1008. PubMed ID: 24938475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
